0403 482 857 [email protected]

Newborn Genetic Test

Postnatal peace of mind

This is a newborn screening test that determines a baby’s risk for 50 inherited disorders, as well as providing personalized genetic information on the metabolism of 20 drugs utilises Next Generation sequencing technology, coupled with the leading genetics bioinformatics software. Postnatal peace is able to offer the most comprehensive and accurate newborn screening test that is over 99.99% accurate.




Each year over 7.9 Million babies are born with birth defects, most of which appear perfectly healthy at birth and come from families with no history of the disorder. Many affected babies are not identified until the appearance of severe and often irreversible symptoms later in life. Many countries run publicly funded programmes to screen newborns for inherited diseases. Currently, all Australian-born babies are screened for five common conditions including congenital hypothyroidism, cystic fibrosis, amino acid disorders including phenylketonuria, organic acidemias and fatty acid oxidation defects. All states and territories except Victoria also screen for galactosaemia. There are a growing number of conditions that could be considered for inclusion in newborn screening programmes and these include, among others, severe combined immunodeficiency and lysosomal storage disease (Newborn Screening in Australia: Position Statement May 2015, Royal Australasian College of Physicians). This leaves thousands of newborns unscreened for any number of potentially manageable disorders and adverse drug reactions




It is suitable for newborns and children up to 5 years of age. I Screens for 50 inherited disorders, which have a combined prevalence rate of 1/400 births aims to achieve early detection, referral and treatment of all babies identified as high risk of these disorders.